E-viri
PDF
Recenzirano
Odprti dostop
-
Matushevskaya, YE. V.; Svirshchevskaya, YE. V.
Vestnik dermatologii i venerologii, 04/2014, Letnik: 90, Številka: 2Journal Article
The article presents the results of international and Russian clinical studies to assess the efficacy and safety of topical antimycotic drugs for the treatment of skin mycoses. The authors demonstrate the advantages of Naftifine (compliance and efficacy) as compared to other topical drugs. Taking into consideration a broad range of its action including antifungal, antibacterial and anti-inflammatory effects, Naftifine can be considered as a first-line drug for the treatment of superficial dermatomycoses including complicated with a bacterial infection.
